NIAID funds laboratory research and clinical trials to address the problem of antimicrobial resistance. NIAID-funded research aims to develop better diagnostics, treatments, and new vaccines that are effective against emerging infectious agents, such as VRE.
NIAID grantees are studying the problem of antibiotic resistance among common bacteria responsible for VRE infections. These projects include:
Similar studies funded by other parts of NIH are under way at various U.S. medical institutions.
Last Updated March 09, 2009